Sort
51,593 grants matching “hepatitis”
Metabolic, and Cardiovascular Effects of GHRH in HIV Infected Patients
$451,961Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2012 · DK
CDPH OA 2011-2015 National HIV Behavioral Surveillance System and Hepatitis Testi
$451,901Karen Elizabeth Mark · California Department Of Public Health · U1B · FY2012 · PS
P450-Base Drug Interactions with Low Spin Drugs
$451,881William M Atkins · University Of Washington · R01 · FY2013 · GM
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia
$451,862Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · DK
The Role of Tcf7l2 in maintaining liver zonation and metabolic homeostasis
$451,852Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2024 · DK
Early Detection of Liver Cancer
$451,837Drexel University · U01 · FY2005 · CA
Structural and mechanistic study of bat NLRP6 inflammasome in detecting RNA viruses
$451,836Chen Shen · Washington University · R01 · FY2025 · AI
The Role of ChREBP in Fructose Induced Metabolic Disease
$451,818Mark A Herman · Duke University · R01 · FY2021 · DK
The Role of ChREBP in Fructose Induced Metabolic Disease
$451,818Mark A Herman · Duke University · R01 · FY2020 · DK
The Role of ChREBP in Fructose Induced Metabolic Disease
$451,818Mark A Herman · Duke University · R01 · FY2022 · DK
The role of acetogenic, methanogenic, and sulfate-reducing bacteria in oxalate metabolism and hyperoxaluria
$451,797Aaron W Miller · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · DK
Membrane homeostasis in adipose physiology and obesity
$451,768Peter J Tontonoz · University Of California Los Angeles · R01 · FY2024 · DK
Preventing Bacterial and Viral Infections among Injection Drug Users
$451,763Michael D Stein · Butler Hospital (Providence, Ri) · R01 · FY2015 · DA
NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling
$451,720Rohit Kohli · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · DK
Gene Silencing as an Antiviral Defense in Animal Cells
$451,672Shou-Wei Ding · University Of California Riverside · R01 · FY2013 · AI
Molecular Determinants of liver sinusoidal endothelial cells for hepatic regeneration
$451,664Shahin Rafii · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DK
Investigation of the mechanism by which NPC1 dysfunction leads to liver disease
$451,638Laura Liscum · Tufts University Boston · R01 · FY2009 · DK
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
$451,600Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2025 · HL
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
$451,597Jill C Fehrenbacher · Indiana University Indianapolis · R01 · FY2022 · CA
Development of humanized transgenic mice for HBV/HIV co-infection studies
$451,591Larisa Y Poluektova · University Of Nebraska Medical Center · R21 · FY2019 · AI
Role of ABCG5 and ABCG8 in Sterol Metabolism
$451,585Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2012 · HL
HEPATIC GENE TRANSFER FOR TREATMENT OF HEMOPHILIAS A &B
$451,567Stanford University · R01 · FY2003 · HL
Contributions of hepatic and intestinal pathways to cholesterol excretion
$451,563Gregory A Graf · University Of Kentucky · R01 · FY2020 · DK
Contributions of hepatic and intestinal pathways to cholesterol excretion
$451,563Gregory A Graf · University Of Kentucky · R01 · FY2018 · DK
Contributions of hepatic and intestinal pathways to cholesterol excretion
$451,563Gregory A Graf · University Of Kentucky · R01 · FY2021 · DK